SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-008912
Filing Date
2021-05-04
Accepted
2021-05-04 17:16:56
Documents
16
Period of Report
2021-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arqt-20210504.htm   iXBRL 8-K 35873
2 EX-99.1 pressreleaseex991q12021.htm EX-99.1 72265
8 a1a821a.jpg GRAPHIC 25530
  Complete submission text file 0001628280-21-008912.txt   303294

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20210504.xsd EX-101.SCH 2408
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arqt-20210504_cal.xml EX-101.CAL 700
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arqt-20210504_def.xml EX-101.DEF 1633
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20210504_lab.xml EX-101.LAB 26303
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20210504_pre.xml EX-101.PRE 13721
9 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20210504_htm.xml XML 11689
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39186 | Film No.: 21889836
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences